Zhejiang Xianju Pharmaceutical Co.Ltd(002332) : rocuronium injection is listed in the seventh batch of national centralized procurement catalogue, and the company will actively participate in the application of centralized procurement

Zhejiang Xianju Pharmaceutical Co.Ltd(002332) disclosed the announcement in the record form of investor relations activities that the sales of rocuronium bromide injection showed a rapid growth this year due to the promotion of related products such as sodium sugeng gluconate (rocuron antagonist). Rocuronium bromide injection is listed in the seventh batch of national centralized procurement catalogue, and the company will actively participate in the national drug centralized procurement declaration.